Palliative care intervention for choice and use of opioids in the last hours of life

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 63, Issue 9, 2008, Pages 974-978

  Bailey, F Amos ^a,b   Ferguson, Laura ^b   Williams, Beverly R ^a,b   Woodby, Lesa L ^a,b   Redden, David T ^a,c   Durham, Rosie M ^a   Goode, Patricia S ^a,b   Burgio, Kathryn L ^a,b  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Comfort care; End of life care; Inpatient; Palliative care; Physician practice; Veterans

Indexed keywords

CODEINE; FENTANYL; HYDROMORPHONE; METHADONE; MORPHINE; OXYCODONE; PETHIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG CHOICE; DYING; DYSPNEA; ELECTRONIC MEDICAL RECORD; EMERGENCY CARE; FEMALE; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSING STAFF; PAIN; PALLIATIVE THERAPY; PHYSICIAN; PRIORITY JOURNAL; STAFF TRAINING; TERMINAL CARE; TERTIARY HEALTH CARE; TIME OF DEATH;

EID: 54249133590     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/63.9.974     Document Type: Article

References (44)

1. The Support Principal Investigators. A controlled trial to improve care for seriously ill hospital patients: the Study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995;274:1591-1598.
2. Singer PA, Martin DK, Kelner M. Quality end-of-life care: patients' perspectives. JAMA. 1999;281:163-168.
3. Portenoy RK, Thaler HT, Konnblith AB, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3:183-189.
4. Morris JN, Suissa S, Sherwood S, et al. Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis. 1986;39:47-62.
5. Hallenbeck J. Palliative care in the final days of life. JAMA. 2005;293:2265-2270.
6. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326:30-34.
7. World Health Organization (WHO). Cancer Pain Relief with a Guide to Opioid Availability, Second Edition. Geneva, Switzerland: WHO Press; 1996.
8. Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death: observations of patients, families, and providers. Ann Intern Med. 2000;132:825-832.
9. Teno JM, Clarridge BR, Casey V, et al. Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88-93.
10. Mercadante S. Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home. Cancer. 1999;85:1849-1858.
11. Ahronheim JC, Morrison RS, Baskin SA, et al. Treatment of the dying in the acute care hospital. Advanced dementia and metastatic cancer. Arch Intern Med. 1996;156:2094-2100.
12. McCarthy EP, Burns RB, Davis RB, Phillips RS. Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003;21:728-735.
13. Cintron A, Hamel MB, Davis RB, et al. Hospitalization of hospice patients with cancer. J Palliat Med. 2003;6:757-768.
14. Lynn J, Teno JM, Phillips RS, et al, for the SUPPORT Investigators. Perceptions by family members of the dying experience of older and seriously ill patient. Ann Intern Med. 1997;126:97-106.
15. Miller SC, Kinzbrunner B, Pettit P, Williams JR. How does the timing of hospice referral influence hospice care in the last days of life? J Am Geriatr Soc. 2003;51:798-806.
16. Vuorinen EJ. Backlash in the treatment of cancer pain: use of opioid analgesics in Finnish general hospital in 1987, 1998 and 1994. J Pain Symptom Manage. 1997;14:286-291.
17. Tolle SW, Hickman SE, Tilden VP, Bubalo JS, Fromme EK. Trends in opioid use over time: 1997 to 1999. J Palliat Med. 2004;7:39-45.
18. Masuda Y, Noguchi H, Kuzuya M, et al. Comparison of medical treatments for the dying in a hospice and a geriatric hospital in Japan. J Palliat Med. 2006;9:152-160.
19. Bailey FA, Burgio KL, Woodby LL, et al. Improving processes of hospital care during the last hours of life. Arch Intern Med. 2005;165:1722-1727.
20. Levy MH. Pharmacologic treatment of cancer pain. N Engl J Med. 1996;335:1124-1132.
21. Christakis N, Lamont EB. Extent and determinants of errors in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ. 2000;329:469-473.
22. Billings JA, Gardner M, Putman AT. A one-day, hospital-wide survey of dying inpatients. J Palliat Med. 2002;5:363-374.
23. Lynn J, Teno JM, Harrell FE. Accurate prognostication of death: opportunities for clinicians. West J Med. 1995;163:250-257.
24. Knaus WA, Farrell FE, Lunn J, et al. The SUPPORT prognostic model: objective estimates of survival for seriously ill hospitalized adults. Ann Intern Med. 1995;122:191-203.
25. Vigano A, Bruera E, Jhangri GS, et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med. 2000;160:861-868.
26. Stuart B, Alexander C, Arenella C. Medical Guidelines for Determining Prognosis in Selected Non-Cancer Diseases. 2nd Ed. Arlington, VA: National Hospice Organization; 1996.
27. Bailey FA. The Palliative Response. Birmingham, AL: Menasha Ridge Press; 2003.
28. Adam J. ABC of palliative care: the last 48 hours. BMJ. 1997;315:1600-1603.
29. Emanuel LL, von Gunten CF, Ferris FD, eds. The Education for Physicians on End-of-Life Care (EPEC) Curriculum. © The EPEC Project, The Robert Wood Johnson Foundation, 1999 (Module 12: Last Hours of Life).
30. Twycross R, Lichter I. The terminal phase. In: Doyle D, Hanks GWC, MacDonald N, eds. Oxford Textbook of Palliative Medicine, 2nd Ed. Oxford, U.K.: Oxford University Press; 1998:977-992.
31. Ferris FD, von Gunten CF, Emanuel LL. Competency in end-of-life care: last hours of life. J Palliat Med. 2003;6:831-839.
32. Davis DA, Thomson MA, Oxman AD, Haynes RB. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.
33. Davis D. Does CME work? An analysis of the effect of educational activities on physician performance or health care outcomes. Int J Psychiatry Med. 1998;28:21-39.
34. Edgington E. Randomization Tests. New York: Marcel Dekker; 1995.
35. Duffy SA, Copeland LA, Hopp FP, Zalenski RJ. 2007. Diagnostic classifications and resource utilization of decedents served by the Department of Veterans Affairs. J Palliat Med. 2007;10:1137-1145.
36. Portenoy RK, Sibirceva U, Smout R, et al. Opioid use and survival at the end of life: a survey of a hospice population. J Pain Symptom Manage. 2006;32:532-540.
37. Stevenson JG, Pearlman M, Green CR, et al. Altering meperidine prescribing patterns in a university teaching hospital. Jt Comm J Qual Saf. 2004;30:277-281.
38. Pappagallo M, Dickerson ED, Hulka S. Palliative care and hospice opioid dosing guidelines with breakthrough (BP) dosing. Am J Hosp Palliat Care. 2000;17:407-413.
39. Moynihan TJ. Use of opioids in the treatment of severe pain in terminally ill patients - dying should not be painful. Mayo Clin Proc. 2003;78:1397-1401.
40. American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 4th Ed. Glenview, IL: American Pain Society; 1999.
41. Siever BA. Pain management and potentially-life-shortening analgesia in the terminally ill child: the ethical implications for pediatric nurses. J Pediatr Nurs. 1994;9:307-312.
42. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20:403-417.
43. Hall S, Gallagher RM, Gracely E, Knowlton C, Weschules D. The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. Pain Med. 2003;4:125-134.
44. Hanks GW, Reid C. Contribution to variability in response to opioids. Support Care Cancer. 2005;13:145-152.